SEC FILE NUMBER: 000-26177
CUSIP NUMBER:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): [x] Form 10-K and Form 10-KSB [ ] Form 11-K
[ ] Form 20-F [ ] Form 10-Q and Form 10-QSB
[ ] Form 10-D [ ] Form N-SAR
[ ] Form N-CSR
For Period Ended: MARCH 31, 2006
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:____________________________
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
______________________________________________________________________________
PART I - REGISTRANT INFORMATION
OMNI MEDICAL HOLDINGS, INC.
______________________________________________________________________________
Full Name of Registrant
______________________________________________________________________________
Former Name if Applicable
2120 WEST LITTLETON BLVD., SUITE 100
______________________________________________________________________________
Address of Principal Executive Office (Street and Number)
LITTLETON, COLORADO 80120
______________________________________________________________________________
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check box if appropriate)
[X] | (a) The reasons described in reasonable detail in Part III of this
| form could not be eliminated without unreasonable effort or
| expense;
[x] | (b) The subject annual report, semi-annual report; transition report
| on Form 10-K, Form 20-F, 11-K, Form N-SAR, Form N-CSR, or
| portion thereof, will be filed on or before the fifteenth
| calendar day following the prescribed due date; or the subject
| quarterly report or transition report on Form 10-Q, or subject
| distribution report on Form 10-D, or portion thereof, will be
| filed on or before the fifth calendar day following the
| prescribed due date; and
[ ] | (c) The accountant's statement or other exhibit required by Rule
| 12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 10-KSB, 11-K,
20-F, 10-Q, 10-QSB, 10-D, N-SAR, N-CSR or the transition report or portion
thereof, could not be filed within the prescribed time period. (Attach Extra
Sheets If Needed)
Our Form 10-KSB for the year ended March 31, 2006, could not
be filed within the prescribed time period because certain
information and data relating to and necessary for the completion of
our financial statements and management's discussion and analysis of
financial condition and results of operations could not be obtained
within such time period without unreasonable effort or expense. We
also had a change of officers involved which transition has slowed
the process.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
DOUG DAVIS 303 703-4576
_________________________________________________________
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months (or for such shorter) period
that the registrant was required to file such reports) been filed? If
answer is no, identify report(s). [x] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or
portion thereof? [ ] Yes [X] No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
OMNI MEDICAL HOLDINGS, INC
_____________________________________________
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: June 29, 2006 By /s/ DOUG DAVIS
----------------------------------
DOUG DAVIS
Chief Executive Officer
INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.
ATTENTION
Intentional Misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).